Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Trade Show

Gilead Sciences to Present at Upcoming Investor Conferences


Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

The live webcasts can be accessed at the company's investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company's website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.


These press releases may also interest you

at 11:05
Baystate Health to build new, state-of-the-art community health center with landmark donation and support from MassMutual
In an effort to improve health equity and meet the growing needs of the Springfield community, Baystate Health today announced a plan to build a comprehensive community health center in the heart of the city, made possible by the generous support of...

at 11:05
United States Pet Market Outlook 2024-2025: Technology Extends Omnimarket Reach with a Projected $190 Billion Industry through 2028 - ResearchAndMarkets.com
The "US Pet Market Outlook, 2024-2025" report has been added to ResearchAndMarkets.com's offering. With the pet industry continuing to trend in omnichannel and omnimarket directions, the publisher anticipates ongoing modest but steady growth across...

at 10:55
Global Glycerol Monostearate Industry Report 2024: $2.09 Billion Market Analysis by Purity, Type, Application & Region 2023-2029 - ResearchAndMarkets.com
The "Global Glycerol Monostearate Market: Analysis By Purity, By Type, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the...

at 10:10
Result of AGM
SHELL PLC RESULT OF ANNUAL GENERAL MEETING Shell plc announces the poll results on the resolutions at its Annual General Meeting held on Tuesday May 21, 2024 at the InterContinental London ? The O2, 1 Waterview Drive, Greenwich Peninsula, London...

at 10:05
Alvotech and Dr. Reddy's Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ("Alvotech"), and Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: 500124 |...

at 10:00
Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the...

More news about Covid-19 virus...


News published on and distributed by: